Palantir Technologies Inc - Class A
NYSE: PLTR
$55.53
+$4.40 (+8.6%)
Closing Price on November 6, 2024
PLTR Articles
A couple of Cathie Wood's Ark Invest funds bought over 2.8 million shares of Palantir on May 11.
Published:
A couple of Cathie Wood's Ark Invest funds bought over 1.3 million shares of Palantir on May 10.
Published:
Even though Palantir Technologies reported better than expected earnings and revenues, investors clearly thought the company should have done better.
Published:
While the week of May 10 won't see as many earnings reports as the past week, there remain plenty to pay attention to as the economy exits its COVID-19 doldrums.
Published:
One of Cathie Wood's Ark Invest funds bought over 1.5 million shares of Palantir on May 4.
Published:
One of Cathie Wood's Ark Invest funds bought over 1.1 million shares of Palantir on April 20.
Published:
One of Cathie Wood's Ark Invest funds bought over 1 million shares of Palantir on April 7.
Published:
24/7 Wall St. has combed over each of the ARK Invest ETFs for the top purchases in March, and we’ve highlighted three stocks that stand above the rest.
Published:
One of Cathie Wood's Ark Invest funds bought over 780,000 shares of Palantir on March 25.
Published:
One of Cathie Wood's Ark Invest funds bought over 1.2 million shares of Palantir on March 24.
Published:
A couple of Cathie Wood's Ark Invest funds bought over 2.6 million shares of Palantir on March 3.
Published:
Two of Cathie Woods Ark ETFs bought over 3 million shares of Palantir Technologies Inc. (NYSE: PLTR). It has been battered by poor earnings and the tech sell-off. However, it has been a long-term...
Published:
Analysts recommended buying shares of the following eight top tech stocks last week, though a few of these seem like contrarian calls.
Published:
Goldman Sachs has raised the price targets on stocks of some companies that delivered the goods in a big way during earnings season. These three momentum tech stocks still look to have some very...
Published:
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh and Palantir Technologies.
Published: